Ouabain inhibited the α1/PD-L1 interaction and thereby enhanced PD-L1 expression; moreover, treatment with ouabain for more than an hour caused progressive downregulation of α1 NKA in NSCLC cells in vitro, which would also be expected to enhance PD-L1 expression. Here, CD274 is linked to non-small cell lung carcinoma.